Fulcrum Therapeutics Inc
Biotechnology
Healthcare
FULC
62.54 M shares
NASDAQ US
traded
23 Sep 2025
listed
no
open
7.47
52 week high
8.85
high
7.55
52 week low
0.00
previous Close
7.45
P/E ratio
market cap
351 M
div yield
0
net incoming
-17.30 M
2.03 %
net profit margin
-1729600000.00 %
0.00 %
operating incoming
-19.82 M
2.88 %
net change in cash
414 K
102.58 %
cash on hand
42.59 M
0.97 %
top